BioWorld

April 12, 2007

View Archived Issues

Transgene, Roche Enter Potential $293M Alliance On HPV Vaccine

Transgene SA entered its first product-development deal, a collaboration worth up to €218 million (US$293) on its late-stage therapeutic vaccine against human papillomavirus-related diseases. (BioWorld Today) Read More

Cell Genesys Boosting Cash Position Via $60M Stock Sale

Read More

Finding Mechanisms Of Breast Cancer Metastasis, In Four Akts

Read More

Diagnostics, Patients' Input Changing Face Of Medicine

Read More

Genaera Restructures Again, To Focus On Obesity Program

Read More

Other News To Note

Read More

Clinic Roundup

Read More